2023 Year in Review: Home Oxygen Therapy.
COPD and supplemental oxygen
ambulatory oxygen
high flow
long-term oxygen
supplemental oxygen and COVID-19
telehealth
telemonitoring
Journal
Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357
Informations de publication
Date de publication:
24 Aug 2024
24 Aug 2024
Historique:
medline:
26
8
2024
pubmed:
26
8
2024
entrez:
24
8
2024
Statut:
epublish
Résumé
Long-term oxygen therapy (LTOT) is a treatment that involves the provision of supplemental oxygen to individuals with respiratory disease to correct hypoxemia in the post-acute care environment. Over 1.5 million adults in the United States use supplemental oxygen for various respiratory disorders. This paper explores literature published on LTOT from September 2022-September 2023. Upon the conclusion of this literature review, 4 distinct categories emerged. This paper highlights the significant findings associated with the 4 categories: supplemental oxygen and COVID-19, telemonitoring, LTOT equipment, and in-home high-flow nasal cannula.
Identifiants
pubmed: 39181721
pii: 69/9/1182
doi: 10.4187/respcare.12070
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1182-1188Informations de copyright
Copyright © 2024 by Daedalus Enterprises.
Déclaration de conflit d'intérêts
Ms Wiles discloses a relationship with Drive Medical, and was a sponsored speaker for medtrade October 2022.